| Literature DB >> 32111933 |
Seon Joo Park1, Jiyeon Lee1,2, Sung Eun Seo1, Kyung Ho Kim1, Chul Soon Park1, Sang Hun Lee3, Hyun Seung Ban4, Byoung Dae Lee5, Hyun Seok Song6, Jinyeong Kim1, Chang-Soo Lee7,8, Joonwon Bae9, Oh Seok Kwon10,11.
Abstract
In this study, ultrasensitive and precise detection of a representative brain hormone, dopamine (DA), was demonstrated using functional conducting polymer nanotubes modified with aptamers. A high-performance aptasensor was composed of interdigitated microelectrodes (IMEs), carboxylated polypyrrole nanotubes (CPNTs) and DA-specific aptamers. The biosensors were constructed by sequential conjugation of CPNTs and aptamer molecules on the IMEs, and the substrate was integrated into a liquid-ion gating system surrounded by pH 7.4 buffer as an electrolyte. To confirm DA exocytosis based on aptasensors, DA sensitivity and selectivity were monitored using liquid-ion gated field-effect transistors (FETs). The minimum detection level (MDL; 100 pM) of the aptasensors was determined, and their MDL was optimized by controlling the diameter of the CPNTs owing to their different capacities for aptamer introduction. The MDL of CPNT aptasensors is sufficient for discriminating between healthy and unhealthy individuals because the total DA concentration in the blood of normal person is generally determined to be ca. 0.5 to 6.2 ng/mL (3.9 to 40.5 nM) by high-performance liquid chromatography (HPLC) (this information was obtained from a guidebook "Evidence-Based Medicine 2018 SCL " which was published by Seoul Clinical Laboratory). The CPNTs with the smaller diameters (CPNT2: ca. 120 nm) showed 100 times higher sensitivity and selectivity than the wider CPNTs (CPNT1: ca. 200 nm). Moreover, the aptasensors based on CPNTs had excellent DA discrimination in the presence of various neurotransmitters. Based on the excellent sensing properties of these aptasensors, the DA levels of exogeneous DA samples that were prepared from PC12 cells by a DA release assay were successfully measured by DA kits, and the aptasensor sensing properties were compared to those of standard DA reagents. Finally, the real-time response values to the various exogeneous DA release levels were similar to those of a standard DA aptasensor. Therefore, CPNT-based aptasensors provide efficient and rapid DA screening for neuron-mediated genetic diseases such as Parkinson's disease.Entities:
Mesh:
Substances:
Year: 2020 PMID: 32111933 PMCID: PMC7048782 DOI: 10.1038/s41598-020-60715-x
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Schematic illustration of cell exocytosis for DA release from PC12 cells via rapid Ca2+ reflux accelerated by K+ ions (upper) and liquid-ion gated FET aptasensors using aptamer-conjugated CPNTs for exogeneous DA detection (down).
Figure 2(a) Schematic of the processes for IME fabrication. (b) Photograph of IMEs and SEM image of the extended active IME array. The prepared IME array was 2 μm wide, 1.5 mm long and 30 nm thick (Au 25/Cr 5 nm).
Figure 3Fabrication protocol of aptasensor based on aptamer-conjugated CPNTs. Chemical conjugation mechanism between CPNTs and aptamer by the condensation reagent DMT-MM.
Figure 4SEM images of CPNTs on IME arrays: (a) CPNT1 (ca. 200 nm in diameter) and (b) CPNT2 (ca. 120 nm in diameter). The insets show transmission electron microscopy (TEM) images of CPNT1 and CPNT2. (c) FT-IR spectroscopy of CPNTs and aptamer-CPNTs. (d) XPS analysis of P2p (ca.133 eV) of the aptamer-conjugated CPNT1 and CPNT2. (e) Fluorescent images of aptamer-CPNTs (right) and FITC-aptamer-CPNTs (left). The image of FITC was observed along the IME arrays.
Figure 5Current-voltage (I-V) curves of (a) CPNT1 and (b) CPNT2 before and after the introduction of aptamer. Characterization of liquid-ion gated aptasensors: (c) schematic illustration of liquid-ion gated aptasensors using CPNTs on the IME array. (d) Output characteristics of liquid-ion gated aptasensors with CPNTs.
Figure 6(a) Schematic illustration of the sensing mechanism between DA and DA aptamer (the inset shows the aptamer sequence with binding site and the red circle with a hydroxyl group in the position 3 of DA). (b) Real-time responses of liquid-ion gated aptasensors to various DA concentrations. (c) DA concentration-dependent real-time responses of aptasensors. (d) DA discrimination by aptasensors under NE, ST and PEA. (e) Extended selectivity of aptasensors toward various neurotransmitters: the most sensitive responses with DA. The error bars, which are in Fig. 6b,d, were calculated as standard deviation (n = 5).
Figure 7(a) Schematic illustration of DA release by Ca2+ and K+. The Ca2+ ion channels with K+ are more active than one without K+. (b) KCl concentration-dependent DA concentration produced by cell exocytosis (the error bars were calculated as standard deviation, n = 5). (c) Real-time responses of CPNT2-aptasensor to exogeneous DA samples released at various KCl concentrations. (d) Selectivity of CPNT2-aptasensor to exogeneous DA sample in mixtures.